Global Health Ltd (MEDANTA) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Global Health Ltd/India (Medanta) reported strong Q3 FY25 results, driven by consistent volume growth and contributions from developing hospitals.
- Total income increased by 12% year-on-year, reaching Rs. 9,595 million.
- Profit after tax (PAT) grew by 16% year-on-year, with improved margins of 14.9%.
- Inpatient and outpatient volumes increased by 13% and 9% year-on-year, respectively.
- The company achieved significant clinical milestones, including robotic surgeries in Lucknow and complex procedures in Gurugram.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.